Details of the Drug

General Information of Drug (ID: DMJONRK)

Drug Name
EIDD-1931
Synonyms N-hydroxycytidine; NHC; NSC-529856; CTK0I1923; DTXSID70326527; NSC529856; SCHEMBL6674536
Indication
Disease Entry ICD 11 Status REF
Coronavirus Disease 2019 (COVID-19) 1D6Y Investigative [1]
Affected Organisms
Influenza VirusSARS-CoVSARS-CoV-2
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C9H13N3O6
Canonical SMILES
C1=CN(C(=O)N=C1NO)C2C(C(C(O2)CO)O)O
InChI
InChI=1S/C9H13N3O6/c13-3-4-6(14)7(15)8(18-4)12-2-1-5(11-17)10-9(12)16/h1-2,4,6-8,13-15,17H,3H2,(H,10,11,16)/t4-,6-,7-,8-/m1/s1
InChIKey
XCUAIINAJCDIPM-XVFCMESISA-N
Cross-matching ID
PubChem CID
197020
CAS Number
3258-02-4
UNII
C3D11PV2O4
DrugBank ID
DB15660
TTD ID
D01SVO
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug

References

1 An Orally Bioavailable Broad-Spectrum Antiviral Inhibits SARS-CoV-2 in Human Airway Epithelial Cell Cultures and Multiple Coronaviruses in Mice. Sci Transl Med. 2020 Apr 6;eabb5883.